Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001140361-22-047671

Options or other derivatives

  • CEO, President acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RODRIGUEZ RAUL R · CEO, President

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-12-28 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +200,000 $2.42 2032-01-24 200,000 200,000 D
Loading xslF345X03/form4.xml…